Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About ImmuneWorks
ImmuneWorks
Reports Graph
IW001 is targeted to idiopathic pulmonary fibrosis (IPF) patients who have autoimmunity against collagen V (40% of all 200,000 IPF patients). IW001 modulates the anti-collagen V immune response and is Phase 2 ready.
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next